Long-Term Outcomes and Sequelae Analysis of Intracranial Germinoma: Need to Reduce the Extended-Field Radiotherapy Volume and Dose to Minimize Late Sequelae
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose We aimed to refine the radiotherapy (RT) volume and dose for intracranial germinoma considering recurrences and long-term toxicities. Materials and Methods Total 189 patients with intracranial germinoma were treated with RT alone (n=50) and RT with upfront chemotherapy (CRT) (n=139). All cases were confirmed histologically. RT fields comprised the extended-field and involved-field only for primary site. The extended-field, including craniospinal, whole brain (WB), and whole ventricle (WV) for cranial field, is followed by involved-field boost. The median follow-up duration was 115 months. Results The relapses developed in 13 patients (6.9%). For the extended-field, cranial RT dose down to 18 Gy exhibited no cranial recurrence in 34 patients. In CRT, 74 patients (56.5%) showed complete response to chemotherapy and no involved-field recurrence with low-dose RT of 30 Gy. WV RT with chemotherapy for the basal ganglia or thalamus germinoma showed no recurrence. Secondary malignancy developed in 10 patients (5.3%) with a latency of 20 years (range, 4 to 26 years) and caused mortalities in six. WB or craniospinal field rather than WV or involved-field significantly increased the rate of hormone deficiencies, and secondary malignancy. RT dose for extended-field correlated significantly with the rate of hormone deficiencies, secondary malignancy, and neurocognitive dysfunction. Conclusion De-intensifying extended-field rather than involved-field or total scheme of RT will be critical to decrease the late toxicities. Upfront chemotherapy could be beneficial for the patients with complete response to minimize the RT dose down to 30 Gy. Prospective trials focused on de-intensification of the extended-field RT are warranted.
Abstract
Purpose We aimed to refine the radiotherapy (RT) volume and dose for intracranial germinoma considering recurrences and long-term toxicities. Materials and Methods Total 189 patients with intracranial germinoma were treated with RT alone (n=50) and RT with upfront chemotherapy (CRT) (n=139). All cases were confirmed histologically. RT fields comprised the extended-field and involved-field only for primary site. The extended-field, including craniospinal, whole brain (WB), and whole ventricle (WV) for cranial field, is followed by involved-field boost. The median follow-up duration was 115 months. Results The relapses developed in 13 patients (6.9%). For the extended-field, cranial RT dose down to 18 Gy exhibited no cranial recurrence in 34 patients. In CRT, 74 patients (56.5%) showed complete response to chemotherapy and no involved-field recurrence with low-dose RT of 30 Gy. WV RT with chemotherapy for the basal ganglia or thalamus germinoma showed no recurrence. Secondary malignancy developed in 10 patients (5.3%) with a latency of 20 years (range, 4 to 26 years) and caused mortalities in six. WB or craniospinal field rather than WV or involved-field significantly increased the rate of hormone deficiencies, and secondary malignancy. RT dose for extended-field correlated significantly with the rate of hormone deficiencies, secondary malignancy, and neurocognitive dysfunction. Conclusion De-intensifying extended-field rather than involved-field or total scheme of RT will be critical to decrease the late toxicities. Upfront chemotherapy could be beneficial for the patients with complete response to minimize the RT dose down to 30 Gy. Prospective trials focused on de-intensification of the extended-field RT are warranted.
참고문헌 (20)
- 도윤식, "An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea, 2013", Brain Tumor Research and Treatment, 5(1), pp.16~23 (2017), 대한뇌종양학회
- 이승훈, "Nationwide Population-Based Incidence and Survival Rates of Malignant Central Nervous System Germ Cell Tumors in Korea, 2005-2012", Cancer Research and Treatment, 49(2), pp.494~501 (2017), 대한암학회
- da Silva NS, "Primary chemotherapy for intracranial germ cell tumors : results of the third international CNS germ cell tumor study", Pediatr Blood Cancer, 54, pp.377~383 (2010)
- Byun HK, "Optimization of intracranial germinoma treatment : a single institution experience with 213 patients supports radiotherapy alone with reduced volume and dose", Int J Radiat Oncol Biology Phys, 105, pp.909~ (2019)
- Lee DS, "Upfront chemotherapy followed by response adaptive radiotherapy for intracranial germinoma : prospective multicenter cohort study", Radiother Oncol, 138, pp.180~186 (2019)
- Calaminus G, "SIOP CNS GCT 96 : final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease", Neuro Oncol, 15, pp.788~796 (2013)
- Jensen AW, "Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma", Int J Radiat Oncol Biol Phys, 77, pp.1449~1456 (2010)
- Cho J, "Low-dose craniospinal irradiation as a definitive treatment for intracranial germinoma", Radiother Oncol, 91, pp.75~79 (2009)
- Nakamura H, "Recurrent intracranial germinoma outside the initial radiation field : a single-institution study", Acta Oncol, 45, pp.476~483 (2006)
- Nguyen QN, "Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure", Cancer, 107, pp.2228~2236 (2006)
- Shirato H, "Impact of margin for target volume in low-dose involved field radiotherapy after induction chemotherapy for intracranial germinoma", Int J Radiat Oncol Biol Phys, 60, pp.214~217 (2004)
- Haas-Kogan DA, "Radiation therapy for intracranial germ cell tumors", Int J Radiat Oncol Biol Phys, 56, pp.511~518 (2003)
- Aoyama H, "Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors", J Clin Oncol, 20, pp.857~865 (2002)
- Eom KY, "Upfront chemotherapy and involved-field radiotherapy results in more relapses than extended radiotherapy for intracranial germinomas : modification in radiotherapy volume might be needed", Int J Radiat Oncol Biol Phys, 71, pp.667~671 (2008)
- Shin KH, "Impacts of elevated level of hCG in serum on clinical course and radiotherapy results in the histology-confirmed intracranial germinomas", Acta Oncol, 40, pp.98~101 (2001)
- Murray MJ, "Consensus on the management of intracranial germ-cell tumours", Lancet Oncol, 16, pp.e470~7 (2015)
- Yen SH, "Optimal treatment for intracranial germinoma: can we lower radiation dose without chemotherapy?", Int J Radiat Oncol Biol Phys, 77, pp.980~987 (2010)
- Shim KW, "Treatment strategy for intracranial primary pure germinoma", Childs Nerv Syst, 29, pp.239~248 (2013)
- Sonoda Y, "Germ cell tumors in the basal ganglia : problems of early diagnosis and treatment", J Neurosurg Pediatr, 2, pp.118~124 (2008)
- Phi JH, "Germinomas in the basal ganglia : magnetic resonance imaging classification and the prognosis", J Neurooncol, 99, pp.227~236 (2010)